Evidence map›Paper›PMID 25105489›Full record

ArticleVirology2014

Phylogeography and epidemic history of hepatitis C virus genotype 4 in Africa.

James C Iles, Jayna Raghwani, G L Abby Harrison, Jacques Pepin, Cyrille F Djoko, Ubald Tamoufe, Matthew LeBreton, Bradley S Schneider, Joseph N Fair, Felix M Tshala and 7 more

Abstract read
In one paragraph

Article in Virology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Exact limits of inference in coalescent models.Theoretical population biology · 2019
    Article
  19. Article
  20. An Efficient, Large-Scale Survey of Hepatitis C Viremia in the Democratic Republic of the Congo Using Dried Blood Spots.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

James C IlesDepartment of Zoology, University of Oxford, South Parks Road, Oxford, OX1 3PS, UK.
Jayna RaghwaniDepartment of Zoology, University of Oxford, South Parks Road, Oxford, OX1 3PS, UK.
G L Abby HarrisonDepartment of Infection & Immunity, Walter & Eliza Hall Institute, Victoria 3052, Australia.
Jacques PepinDepartment of Microbiology and Infectious Diseases, Université de Sherbrooke, Sherbrooke, Canada.
Cyrille F DjokoGlobal Viral, Yaoundé, Cameroon.
Ubald TamoufeMetabiota, San Francisco, USA.
Matthew LeBretonMetabiota, San Francisco, USA.
Bradley S SchneiderMetabiota, San Francisco, USA.
Joseph N FairMetabiota, San Francisco, USA.
Felix M TshalaDepartment of Military Health, Ministry of Defense, Kinshasa, Democratic Republic of the Congo.
Patrick K KayembeKinshasa School of Public Health, Kinshasa, Democratic Republic of the Congo.
Jean Jacques MuyembeNational Institute of Biomedical Research, Kinshasa, Democratic Republic of the Congo.
Samuel Edidi-BasepeoNational AIDS Control Program, Reference Laboratory, Kinshasa, Democratic Republic of the Congo.
Nathan D WolfeMetabiota, San Francisco, USA; Stanford University Program in Human Biology, Stanford, USA.
Peter SimmondsRoslin Institute, University of Edinburgh, Edinburgh, UK.
Paul KlenermanPeter Medawar Building for Pathogen Research, University of Oxford, Oxford, UK.
Oliver G PybusDepartment of Zoology, University of Oxford, South Parks Road, Oxford, OX1 3PS, UK. Electronic address: oliver.pybus@zoo.ox.ac.uk.

Funding

TUBERCULOSIS INTERNATIONAL TRAINING AND RESEARCH PROGRAMD43TW000010 · FIC · JOHNS HOPKINS UNIVERSITY · PI BEYRER, CHRISTOPHER C. · 1988 to 2012
$19.8M
NIH Director's Pioneer Award (RMI)DP1OD000370 · OD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI WOLFE, NATHAN D · 2005 to 2009
$3.4M
FIC NIH HHS 2D43TW000010-16/17NIH HHS DP1 OD000370NIH HHS DP1-OD000370Wellcome Trust 091663Wellcome Trust 095831Wellcome Trust WT091663MA
6 · The paper itself

Abstract

HCV genotype 4 is prevalent in many African countries, yet little is known about the genotype׳s epidemic history on the continent. We present a comprehensive study of the molecular epidemiology of genotype 4. To address the deficit of data from the Democratic Republic of the Congo (DRC) we PCR amplified 60 new HCV isolates from the DRC, resulting in 33 core- and 48 NS5B-region sequences. Our data, together with genotype 4 database sequences, were analysed using Bayesian phylogenetic approaches. We find three well-supported intra-genotypic lineages and estimate that the genotype 4 common ancestor existed around 1733 (1650-1805). We show that genotype 4 originated in central Africa and that multiple lineages have been exported to north Africa since ~1850, including subtype 4a which dominates the epidemic in Egypt. We speculate on the causes of the historical intra-continental spread of genotype 4, including population movements during World War 2.

Indexed as

PhylogenyAdultAfricaAgedEvolution, MolecularFemaleHepacivirusHepatitis CHumansMaleMiddle AgedMolecular Sequence DataPhylogeographyYoung AdultAfricaDRCEgyptHepatitis CMolecular clockMolecular epidemiologyPhylogenyPrevalenceSkyline plot

Identifiers

PMID25105489
PMCPMC4162651

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.